Achondroplasia Classification and external resources
Jason Acuña, alias "Wee-Man", a star of Jackass
ICD-10 Q77.4 ICD-9 756.4 OMIM 100800 DiseasesDB 80 eMedicine radio/809 MeSH D000130
Achondroplasia dwarfism ( //) occurs as a sporadic mutation in approximately 85% of cases (associated with advanced paternal age) or may be inherited in an autosomal dominant genetic disorder that is a common cause of dwarfism. If both parents of a child have achondroplasia, and both parents pass on the mutant gene, then it is very unlikely that the homozygous child will live past a few months of its life. The disorder itself is caused by a change in the DNA for fibroblast growth factor receptor 3 which causes an abnormality of cartilage formation. Achondroplastic dwarfs have short stature, with an average adult height of 131 cm (4 feet, 3½ inches) for males and 123 cm (4 feet, ½ inch) for females.
The prevalence is approximately 1 in 25,000.
In normal circumstances, FGFR3 has a negative regulatory effect on bone growth. In achondroplasia, the mutated form of the receptor is constitutively active and this leads to severely shortened bones.
People with achondroplasia have one normal copy of the fibroblast growth factor receptor 3 gene and one mutant copy. Two copies of the mutant gene are invariably fatal before or shortly after birth. Only one copy of the gene has to be present for the disorder to occur. Therefore, a person with achondroplasia has a 50% chance of passing on the gene to his or her offspring, meaning that there will be a 50% chance that each child will have achondroplasia. Since it is fatal to have two copies (homozygous), if two people with achondroplasia have a child, there is a 25% chance of the child dying shortly after birth, a 50% chance the child will have achondroplasia, and a 25% chance the child will have an average phenotype. People with achondroplasia can be born to parents that do not have the condition. This is the result of a new mutation.
New gene mutations leading to achondroplasia are associated with increasing paternal age (over 35 years old). Studies have demonstrated that new gene mutations for achondroplasia are exclusively inherited from the father and occur during spermatogenesis; it is theorized that oogenesis has some regulatory mechanism that hinders the mutation from originally occurring in females (although females are still readily able to inherit and pass on the mutant allele). More than 99% of achondroplasia is caused by two different mutations in the fibroblast growth factor receptor 3 (FGFR3). In about 98% of cases, a G to A point mutation at nucleotide 1138 of the FGFR3 gene causes a glycine to arginine substitution (Bellus et al. 1995, Shiang et al. 1994, Rousseau et al. 1996). About 1% of cases are caused by a G to C point mutation at nucleotide 1138. The mutant gene was discovered by John Wasmuth and his colleagues in 1994.
Achondroplasia can be detected before birth by the use of prenatal ultrasound. A DNA test can be performed before birth to detect homozygosity, wherein two copies of the mutant gene are inherited, a lethal condition leading to stillbirths.
A skeletal survey is useful to confirm the diagnosis of achondroplasia. The skull is large, with a narrow foramen magnum, and relatively small skull base. The vertebral bodies are short and flattened with relatively large intervertebral disk height, and there is congenitally narrowed spinal canal. The iliac wings are small and squared, with a narrow sciatic notch and horizontal acetabular roof. The tubular bones are short and thick with metaphyseal cupping and flaring and irregular growth plates. Fibular overgrowth is present. The hand is broad with short metacarpals and phalanges, and a trident configuration. The ribs are short with cupped anterior ends. If the radiographic features are not classic, a search for a different diagnosis should be entertained. Because of the extremely deformed bone structure, people with achondroplasia are often "double jointed".
The diagnosis can be made by fetal ultrasound by progressive discordance between the femur length and biparietal diameter by age. The trident hand configuration can be seen if the fingers are fully extended.
Another distinct characteristic of the syndrome is thoracolumbar gibbus in infancy.
At present, there is no known treatment for achondroplasia, even though the cause of the mutation in the growth factor receptor has been found. Therapies and diagnostic methodologies are likely to be looked into and developed.
Although used by those without achondroplasia to aid in growth, human growth hormone does not help people with achondroplasia. However, if desired, the controversial surgery of limb-lengthening will lengthen the legs and arms of someone with achondroplasia.
Usually, the best results appear within the first and second year of therapy. After the second year of GH therapy, beneficial bone growth decreases. Therefore, GH therapy is not a satisfactory long term treatment.
Achondroplasia is one of several congenital conditions with similar presentations, such as osteogenesis imperfecta, multiple epiphyseal dysplasia tarda, achondrogenesis, osteopetrosis, and thanatophoric dysplasia. This makes estimates of prevalence difficult, with changing and subjective diagnostic criteria over time. One detailed and long-running study in the Netherlands found that the prevalence determined at birth was only 1.3 per 100,000 live births. However, another study at the same time found a rate of 1 per 10,000.
In other species
Based on their disproportionate dwarfism, some dog breeds traditionally have been classified as "achondroplastic." This is the case for the dachshund, basset hound, and bulldog breeds, to mention a few.  Histological studies in some achondroplastic dog breeds have shown altered cell patterns in cartilage that are very similar to those observed in humans exhibiting achondroplasia. 
- Achondroplasia in children
- ^ Wynn J, King TM, Gambello MJ, Waller DK, Hecht JT (2007). "Mortality in achondroplasia study: A 42-year follow-up". Am. J. Med. Genet. A 143 (21): 2502–11. doi:10.1002/ajmg.a.31919. PMID 17879967.
- ^ Richette P, Bardin T, Stheneur C (2007). "Achondroplasia: From genotype to phenotype". Joint Bone Spine 75 (2): 125–30. doi:10.1016/j.jbspin.2007.06.007. PMID 17950653.
- ^ Dakouane Giudicelli M, Serazin V, Le Sciellour CR, Albert M, Selva J, Giudicelli Y (2007). "Increased achondroplasia mutation frequency with advanced age and evidence for G1138A mosaicism in human testis biopsies". Fertil Steril 89 (6): 1651–6. doi:10.1016/j.fertnstert.2007.04.037. PMID 17706214.
- ^ "Achondroplasia Pelvis". Archived from the original on 2007-10-22. http://web.archive.org/web/20071022201339/http://stevensorenson.com/residents6/achondroplasia_pelvis.htm. Retrieved 2007-11-28.
- ^ Kitoh H, Kitakoji T, Tsuchiya H, Katoh M, Ishiguro N (2007). "Distraction osteogenesis of the lower extremity in patients that have achondroplasia/hypochondroplasia treated with transplantation of culture-expanded bone marrow cells and platelet-rich plasma". J Pediatr Orthop 27 (6): 629–34. doi:10.1097/BPO.0b013e318093f523. PMID 17717461.
- ^ a b Vajo, Z; Francomano, CA; Wilkin, DJ (2000). "The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans.". Endocrine reviews 21 (1): 23–39. doi:10.1210/er.21.1.23. PMID 10696568.
- ^ Aviezer, D; Golembo, M; Yayon, A (2003). "Fibroblast growth factor receptor-3 as a therapeutic target for Achondroplasia--genetic short limbed dwarfism.". Current drug targets 4 (5): 353–65. doi:10.2174/1389450033490993. PMID 12816345.
- ^ a b Online 'Mendelian Inheritance in Man' (OMIM) ACHONDROPLASIA; ACH -100800
- ^ Jones T, Hunt R. The musculoskeletal system: In: Jones T, Hunt R, eds. Veterinary Pathology, 5th ed. Philadelphia: Lea & Febiger; 1979:1175-1176.
- ^ 5. Willis MB. Inheritance of specific skeletal and structural defects. In: Willis MB, eds. Genetics of the Dog. 1st ed. Great Britain: Howell Book House; 1989:119-120.
- ^ Braund K, Ghosh P. Morphological studies of the canine intervertebral disc. The assignment of the beagle to the achondroplastic classification. Res Vet Sci 1975;19:167-172
- GeneReviews/NCBI/NIH/UW entry on Achondroplasia
- OMIM entries on Achondroplasia
- UK Support charity for individuals and families with Achondroplasia and other forms for restricted growth
Osteochondrodysplasia (Q77–Q78, 756.4–756.5) Osteodysplasia/
(including dwarfism)Other dwarfism
Genetic disorder, membrane: cell surface receptor deficiencies G protein-coupled receptor
(including hormone)Class AClass BClass CCASR (Familial hypocalciuric hypercalcemia)Class FFZD4 (Familial exudative vitreoretinopathy 1)
growth factor)ROR2 (Robinow syndrome) · FGFR1 (Pfeiffer syndrome, KAL2 Kallmann syndrome) · FGFR2 (Apert syndrome, Antley-Bixler syndrome, Pfeiffer syndrome, Crouzon syndrome, Jackson-Weiss syndrome) · FGFR3 (Achondroplasia, Hypochondroplasia, Thanatophoric dysplasia, Muenke syndrome) · INSR (Donohue syndrome · Rabson–Mendenhall syndrome) · NTRK1 (Congenital insensitivity to pain with anhidrosis) · KIT (KIT Piebaldism, Gastrointestinal stromal tumor)
JAK-STAT TNF receptor Lipid receptor Other/ungroupedEDAR (EDAR Hypohidrotic ectodermal dysplasia) · PTCH1 (Nevoid basal cell carcinoma syndrome) · BMPR1A (BMPR1A Juvenile polyposis syndrome) · IL2RG (X-linked severe combined immunodeficiency)
Wikimedia Foundation. 2010.
Look at other dictionaries:
achondroplasia — n. 1. a skeletal disorder beginning before birth; cartilage is converted to bone resulting in dwarfism. [WordNet 1.5] … The Collaborative International Dictionary of English
achondroplasia — achondroplasia. См. врожденная хондродистрофия. (Источник: «Англо русский толковый словарь генетических терминов». Арефьев В.А., Лисовенко Л.А., Москва: Изд во ВНИРО, 1995 г.) … Молекулярная биология и генетика. Толковый словарь.
achondroplasia — [ə kän΄drə plā′zhə, ə kän΄drə plā′zhē ə] n. [ModL: see A 2 & CHONDRO & PLASIA] a congenital disorder of bone formation that results in deformities and dwarfing of the skeleton achondroplastic [ā΄känplas′tik] adj … English World dictionary
Achondroplasia — The most common form of short stature with disproportionately short limbs dwarfism with short arms and legs. Achondroplasia is caused by mutation in the fibroblast growth factor receptor 3 gene (FGFR3), which is located on chromosome 4 in… … Medical dictionary
achondroplasia — achondroplastic /ay kon dreuh plas tik/, adj. /ay kon dreuh play zheuh, zhee euh, zee euh/, n. Pathol. defective conversion of cartilage into bone, esp. at the epiphyses of long bones, producing a type of dwarfism. [1890 95; A 6 + CHONDRO +… … Universalium
Achondroplasia — achondroplazija statusas T sritis gyvūnų raida, augimas, ontogenezė, embriologija atitikmenys: lot. Achondroplasia ryšiai: platesnis terminas – kaulinė … Veterinarinės anatomijos, histologijos ir embriologijos terminai
Achondroplasia — kremzlės distrofija statusas T sritis embriologija atitikmenys: lot. Achondroplasia ryšiai: platesnis terminas – kaulinė sinonimas – achondroplazija … Medicininės histologijos ir embriologijos vardynas
achondroplasia — noun Etymology: New Latin, from a + chondr + plasia Date: circa 1893 a genetic disorder disturbing normal growth of cartilage, resulting in a form of dwarfism characterized by a usually normal torso and shortened limbs, and usually inherited as… … New Collegiate Dictionary
achondroplasia — Failure of endochondral ossification responsible for a form of dwarfism; caused by an autosomal dominant mutation. Relatively high incidence (1: 20,000 live births), mostly (90%) new mutations. Also known as chondrodystrophia fetalis … Dictionary of molecular biology
achondroplasia — noun A genetic disorder, the most common form of short limb dwarfism … Wiktionary